Company: PETVW
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001493152-25-006783
Chunk: 48

Company: PetVivo Holdings, Inc.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part I, Item 1
Chunk 48
---
 administrative (“G&A”) expenses and sales and marketing expenses
related to the sale of our Spryng™ products.

General
and administrative (“G&A”) expenses were $3,685,186 and $4,737,374 for the nine months ended December 31, 2024 and 2023,
respectively. General and administrative expenses include compensation and benefits, contracted services, legal and consulting fees,
and stock compensation expenses.

31

Sales
and marketing expenses were $1,878,180 and $3,053,184 for the nine months ended December 31, 2024 and 2023, respectively. Sales and marketing
expenses include compensation, consulting, tradeshows, andcompensation costs to support the launch of our Spryng™ product.

Research
and development (“R&D”) expenses were $1,224,642 and $1,004,780 for the nine months ended December 31, 2024 and 2023,
respectively. The increase was related to clinical studies and efforts to support the launch of Spryng™.

Operating
Loss. As a result of the foregoing, our operating loss was $5,975,878 and $7,971,544 for the nine months ended December 31, 2024
and 2023, respectively. The decrease was related to cost-cutting initiatives in general and administrative and sales and marketing expenses.

Other
Expense. Other expense was $3,716 and $333,034 for the nine months ended December 31, 2024 and 2023, respectively. Other expense
in 2023 consisted of loss on extinguishment of debt and a settlement expense to David Masters.

Net
Loss. Our net loss for the nine months ended December 31, 2024 was $5,979,594 or ($0.30) per share as compared to a net loss
of $8,304,578 or ($0.64) per share for the nine months ended December 31, 2023. The decrease was related to cost-cutting initiatives
in general and administrative expenses and sales and marketing expenses. The weighted average number of shares outstanding was 19,786,608
compared to 12,976,851 for the nine months ended December 31, 2024 and 2023, respectively.

LIQUIDITY
AND CAPITAL RESOURCES

As
of December 31, 2024, our current assets were $1,226,829, including